|
|
|
|
LEADER |
00000cam a2200000Ia 4500 |
001 |
SCIDIR_ocn973191533 |
003 |
OCoLC |
005 |
20231120112213.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
170218s2017 enk ob 001 0 eng d |
010 |
|
|
|a 2016960838
|
040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OPELS
|d UPM
|d N$T
|d MERER
|d OCLCQ
|d OTZ
|d U3G
|d D6H
|d U3W
|d WYU
|d OCLCA
|d OCLCQ
|d YDX
|d OCLCQ
|d OCLCA
|d OCLCQ
|d OCLCA
|d OCLCQ
|d S2H
|d OCLCO
|d VT2
|d OCLCO
|d OCLCF
|d OCLCQ
|d CASUM
|d SFB
|d OCLCO
|
016 |
7 |
|
|a 101707081
|2 DNLM
|
019 |
|
|
|a 973831648
|a 1066605718
|a 1086010179
|a 1235846195
|
020 |
|
|
|a 9780128094907
|q (electronic bk.)
|
020 |
|
|
|a 0128094907
|q (electronic bk.)
|
020 |
|
|
|a 0128091991
|
020 |
|
|
|a 9780128091999
|
020 |
|
|
|z 9780128094907
|
020 |
|
|
|z 0128094907
|
020 |
|
|
|z 9780128091999
|
035 |
|
|
|a (OCoLC)973191533
|z (OCoLC)973831648
|z (OCoLC)1066605718
|z (OCoLC)1086010179
|z (OCoLC)1235846195
|
050 |
|
4 |
|a RA1270.N36
|
060 |
|
4 |
|a 2017 E-036
|
060 |
|
4 |
|a QT 36.5
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
082 |
0 |
4 |
|a 615.9/02
|2 22
|
245 |
0 |
0 |
|a Adverse effects of engineered nanomaterials :
|b exposure, toxicology, and impact on human health /
|c edited by Bengt Fadeel, Antonio Pietroiusti, Anna A. Shvedova.
|
250 |
|
|
|a 2nd ed.
|
260 |
|
|
|a London :
|b Academic Press,
|c 2017.
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Cover; Title page; Copyright page; Contents; Contributors; About the Editors; Preface; Section A -- Engineered nanomaterials: hazard, exposure, risk assessment; Chapter 1 -- Bio-Nano Interactions; Introduction; Protein Corona on Nanoparticles; Development of the Protein Corona; Hard Corona Versus Soft Corona; The Biomolecule Corona Composition; Dynamic Formation of the Biocorona; Impact of the NP-Biomolecule Corona on Human Systems; In Vitro Studies; In Vivo Studies; Microbiome Interactions; Nanotoxicity and the Biomolecule Corona; Conclusions; Take-Home Messages; Acknowledgments; References.
|
505 |
8 |
|
|a Chapter 2 -- Physicochemical CharacterizationIntroduction; Overview of Key Physicochemical Parameters; Modalities of Physicochemical Characterization; Particle Size, Size Distribution, Agglomeration, and Aggregation; Shape; Specific Surface Area and Porosity; Chemical Composition, Purity, and Crystal Structure (Crystallinity); Surface Chemistry (and Contamination); Surface Charge Density and Stability in Dispersion; Dispersibility and Solubility; Dustiness; Sample Preparation and Dispersion Media; Data Collection and Interpretation; Take-Home Messages; Acknowledgments; Disclaimer; References.
|
505 |
8 |
|
|a Chapter 3 -- Toxicity Tests: In Vitro and In VivoIntroduction; Methods for Visualizing Cellular Uptake and Biodistribution; Evaluation of Transport and Uptake of ENM In Vitro and In Vivo; In Vitro Toxicity Tests; Cytotoxicity Tests; Limitations of In Vitro Tests; New In Vitro Test Principles; Validated Cytotoxicity Tests; Genotoxicity Tests; Ex Vivo Models; In Vivo Toxicity Testing; Toxicokinetics; Immunological Responses; Chronic Toxicity and Carcinogenicity; Considerations for Selection of Toxicity Tests: In Vitro/In Vivo Comparison; Conclusions; Take-Home Messages; Acknowledgments.
|
504 |
|
|
|a ReferencesChapter 4-Computational Approaches; Introduction; Challenges in Modeling Nanoparticle Biological Effects; Examples of Nanotoxicology Modeling Approaches; Quantum Chemical Studies of Toxicity of Nanoparticles; Statistical Modeling and Machine Learning Methods; Nanotoxicological Fingerprints to Classify Nanomaterials; Molecular Modeling and Molecular Dynamics Methods; Elucidating Interactions Between Nanomaterials and Proteins; Other Modeling Approaches for Nanotoxicology; Conclusions; Take-Home Messages; References; Chapter 5-Exposure Assessment; Background.
|
505 |
8 |
|
|a How can Workers be Exposed to ENMs?Exposure Routes; Characterization of Behavior of ENMs; Challenges to Assess Exposure to ENMs; Exposure Assessment of ENMs in Workplaces; Evidence for Release of Engineered Nanoparticles in the Workplace; Harmful Effects on Workers; How to Measure Nanoparticles: Metrics; How to Measure Nanoparticles: Measurement Strategies; Instruments Measuring Number Concentration; Instruments Measuring Surface Concentration; Instruments Measuring Mass Concentration; Instruments Giving Indirect Estimates; Sample Collection and Characterization.
|
500 |
|
|
|a ENM Modifications After Their Release.
|
588 |
0 |
|
|a Print version record.
|
520 |
0 |
|
|a Bio-nano interactions / Dana Westmeier, Shirley K. Knauer, Roland H. Stauber, Dominic Docter -- Physicochemical characterization / Kristen Rasmussen, Hubert Rauscher, Agnieszka Mech -- Toxicity tests / Maria Dusinska, Elise Rund�en-Pran, J�urgen Schnekenburger, Jun Kanno -- Computational approaches / Tu C. Le, Vidana Epa, Lang Tran, Dave Winkler -- Exposure Assessment / Kai Savolainen, Antonio Pietroiusti -- Biomonitoring / Enrico Bergamaschi, Irirna Guseva Canu, Adriele Prina-Mello, Regulation and legislation / Kirsten Rasmussen, Brigit Sokull-Kl�uttgen, IL Je Yu, Jun Kanno, Akihiro Hirose, Maureen R. Gwinn -- Risk assessment and risk management / Robert Landsiedel, Ursula G. Sauer, Wim H De Jong -- Respiratory system, part one / Craig A. Plooand, Ken Donaldson -- Respiratory system, part two / Harri Alenius, Michael R. Shurin, Galina V. Shurin, Don Beezhold, Anna A. Shvedova -- Cardiovascular system / Jennifer B. Raftis, Nicholas L. Mills, Rodger Duffin -- Neurological system / Myrtill Simk�o, Mats-olof Mattsson, Robert A. Yokel -- Immune system / Diana Boraschi, Bengt Fadeel, Albert Duschl -- Endorine system / Xuefei Lu, Yong Zhu, Tao Zhu -- Skin / Nancy A. Monteiro-Riviere, Francesca Larese Filon -- Gastrointestinal system / Mark A. Jepson, Hans Bouwmeester -- Reproduction and development / Luisa Campagnolo, Karin S. Hougard -- Genotoxicitiy and cancer / Shareen H. Doak, Ying Liu, Chunying Chen.
|
650 |
|
0 |
|a Nanostructured materials
|x Toxicology.
|
650 |
|
0 |
|a Risk assessment.
|
650 |
1 |
2 |
|a Nanostructures
|x adverse effects
|0 (DNLM)D049329Q000009
|
650 |
2 |
2 |
|a Nanostructures
|x toxicity
|0 (DNLM)D049329Q000633
|
650 |
2 |
2 |
|a Environmental Exposure
|x adverse effects
|0 (DNLM)D004781Q000009
|
650 |
2 |
2 |
|a Risk Assessment
|0 (DNLM)D018570
|
650 |
|
6 |
|a Nanomat�eriaux
|0 (CaQQLa)201-0258061
|x Toxicologie.
|0 (CaQQLa)201-0379898
|
650 |
|
6 |
|a �Evaluation du risque.
|0 (CaQQLa)201-0139195
|
650 |
|
7 |
|a risk assessment.
|2 aat
|0 (CStmoGRI)aat300263660
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Risk assessment
|2 fast
|0 (OCoLC)fst01098146
|
655 |
|
0 |
|a Electronic books.
|
655 |
|
4 |
|a Internet Resources.
|
655 |
|
4 |
|a Portraits.
|
700 |
1 |
|
|a Fadeel, Bengt,
|e editor.
|
700 |
1 |
|
|a Pietroiusti, Antonio,
|e editor.
|
700 |
1 |
|
|a Shvedova, Anna A.,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|t Adverse effects of engineered nanomaterials.
|b 2nd ed.
|d London : Academic Press, 2017
|z 9780128091999
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128091999
|z Texto completo
|